RUSSO, RAFFAELE
RUSSO, RAFFAELE
Effectiveness of Golimumab as Second Anti-TNFα Drug in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis in Italy: GO-BEYOND, a Prospective Real-World Observational Study
2022-01-01 D'Angelo, S; Tirri, E; Giardino, Am; Mattucci-Cerinic, M; Dagna, L; Santo, L; Ciccia, F; Frediani, B; Govoni, M; Bobbio Pallavicini, F; Grembiale, Rd; Delle Sedie, A; Mulè, R; Cantatore, Fp; Foti, R; Gremese, E; Conigliaro, P; Salaffi, F; Viapiana, O; Cauli, A; Giacomelli, R; Arcarese, L; Guggino, G; Russo, R; Puenpatom, A; Capocotta, D; Nacci, F; Anelli, Mg; Picerno, V; Binetti, C; Iannone, F.
Real-world effectiveness and persistence of golimumab as second-line anti-TNFα drug in rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis patients in Italy: GO-BEYOND, a 12-month prospective observational study
2024-01-01 D'Angelo, S; Tirri, E; Giardino, Am; De Rosa, T; Matucci-Cerinic, M; Dagna, L; Santo, L; Ciccia, F; Frediani, B; Govoni, M; Pallavicini, Fb; Grembiale, Rd; Sedie, Ad; Mulè, R; Cantatore, Fp; Foti, R; Gremese, E; Conigliaro, P; Salaffi, F; Viapiana, O; Cauli, A; Giacomelli, R; Arcarese, L; Guggino, G; Russo, R; Puenpatom, A; Capocotta, D; Nacci, F; Anelli, Mg; Picerno, V; Binetti, C; Iannone, F; GO-BEYOND Italy Study, Investigators.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Effectiveness of Golimumab as Second Anti-TNFα Drug in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis in Italy: GO-BEYOND, a Prospective Real-World Observational Study | 1-gen-2022 | D'Angelo, S; Tirri, E; Giardino, Am; Mattucci-Cerinic, M; Dagna, L; Santo, L; Ciccia, F; Frediani, B; Govoni, M; Bobbio Pallavicini, F; Grembiale, Rd; Delle Sedie, A; Mulè, R; Cantatore, Fp; Foti, R; Gremese, E; Conigliaro, P; Salaffi, F; Viapiana, O; Cauli, A; Giacomelli, R; Arcarese, L; Guggino, G; Russo, R; Puenpatom, A; Capocotta, D; Nacci, F; Anelli, Mg; Picerno, V; Binetti, C; Iannone, F. | |
| Real-world effectiveness and persistence of golimumab as second-line anti-TNFα drug in rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis patients in Italy: GO-BEYOND, a 12-month prospective observational study | 1-gen-2024 | D'Angelo, S; Tirri, E; Giardino, Am; De Rosa, T; Matucci-Cerinic, M; Dagna, L; Santo, L; Ciccia, F; Frediani, B; Govoni, M; Pallavicini, Fb; Grembiale, Rd; Sedie, Ad; Mulè, R; Cantatore, Fp; Foti, R; Gremese, E; Conigliaro, P; Salaffi, F; Viapiana, O; Cauli, A; Giacomelli, R; Arcarese, L; Guggino, G; Russo, R; Puenpatom, A; Capocotta, D; Nacci, F; Anelli, Mg; Picerno, V; Binetti, C; Iannone, F; GO-BEYOND Italy Study, Investigators. |